Annals of Indian Academy of Neurology (Jan 2008)

Quality of life in <i>Wilson&#x2032;s disease</i>

  • Komal Kumar R,
  • Taly A,
  • Nair K.P.S,
  • Sinha S,
  • Prashanth L,
  • Vidya N,
  • Arunodaya G,
  • Rao S

Journal volume & issue
Vol. 11, no. 1
pp. 37 – 40

Abstract

Read online

Background: Assessment of Quality of life (QoL) is fast assuming significance as the measure of health in many disorders. Aim: To correlate clinical severity and QoL in patients with Wilson′s disease (WD). Materials and Methods: We evaluated patients of WD on regular follow up for at least two years and aged over 18 years using Neurological Symptom Score (NSS) for clinical severity and WHO-BREF for QoL at a university teaching hospital. Patients with inability to respond to the questionnaire due to behavioral problems, low IQ or other disease related factors were excluded. These 30 patients (M:F:: 23:7) had a mean age of 27.97 ± 11.16 years at evaluation and the mean duration of treatment of 9.2 ± 6.4 years. Results: All four domains of WHO-QoL-BREF viz., Physical, Psychological, Social and Environmental correlated well with each other ( p < 0.01). The NSS correlated inversely with the physical domain ( p < 0.02), while the duration of treatment had a positive correlation with the physical domain ( p < 0.01). None of the other features of QoL showed any significant correlation with age, NSS or duration of treatment. Conclusion: QoL is complementary to formal neurological assessment and should be routinely incorporated in the evaluation of outcome of patients with WD and other chronic neurological disorders.

Keywords